SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

StarkNet is a permissionless decentralized Layer 2 (L2) validity rollup, built to allow Ethereum to scale via cryptographic protocols called STARKs, without compromising Ethereum’s core principles of decentralization, transparency, inclusivity and security. The StarkNet Token is needed to operate the ecosystem, maintain and secure it, decide on its values and strategic goals, and direct its evolution. This token will be required for (i) governance, (ii) payment of transaction fees on StarkNet, and (iii) participation in StarkNet’s consensus mechanism.

Starknet

STRKs sharp rally and rising volume have drawn attention, with traders linking the move to Starknets privacy and Bitcoin-DeFi initiatives and its post-quantum security narrative. Sentiment is broadly bullish on momentum and the projects technology, though some traders question whether gains can hold amid token-unlock and dilution concerns.

Injective is an interoperable Layer 1 blockchain designed for DeFi applications. It provides developers with on-chain financial infrastructure modules to build dApps such as decentralized exchanges, prediction markets, and lending protocols. Its decentralized cross-chain bridging infrastructure offers compatibility with most blockchains, including EVM chains like Ethereum and non-EVM chains like Solana.

Injective

Injectives proposed supply-squeeze update, which traders say could double INJs deflation rate if approved, is fueling bullish discussion alongside progress in tokenization and institutional finance. Optimists point to burns, staking and ecosystem growth, while skeptics remain wary of the tokens prolonged decline and question whether those developments will translate into sustained demand.

Bitdeer Technologies Group engages in the cryptocurrency mining industry. It generates income through its proprietary mining datacenters. The firm handles complex processes involved in computing such as equipment procurement, transport logistics, datacenter design and construction, equipment management, and daily operations. The company was founded by Wu Jihan in December 2021 and is headquartered in Singapore.

Bitdeer Technologies Group. - Ordinary Shares - Class A

Bitdeer Technologies Holding Co

Bitdeers AI/HPC expansion is drawing attention, particularly its announced long-term Norway data-center lease, while the companys at-the-market share offering has fueled concerns about dilution amid weak price action. Bulls point to the AI infrastructure opportunity alongside Bitcoin mining, while skeptics question whether the growth will translate into shareholder gains.

Alignment Healthcare, Inc. is a holding company, which offers a consumer-centric platform that delivers customized health care solutions to seniors and those who need it most, the chronically ill and frail, through its Medicare Advantage plans. It offers health plan options through Alignment Health Plan, and partners with select health plans to help deliver better benefits at lower costs. The company was founded by John E. Kao in 2013 and is headquartered in Orange, CA.

Alignment Healthcare Inc

Alignment Healthcares largest California Medicare Advantage contract fell from four to 3.5 stars, putting its eligibility for quality bonus payments at risk and driving a sharp selloff. Traders debate how much this could weigh on future earnings, with some expecting the company to challenge the rating and others viewing the potential 2028 impact as substantial.

Wachovia Corporation, a financial holding company, provides commercial and retail banking services, and other financial services. Wachovia was a diversified financial services company based in Charlotte, North Carolina. Before its acquisition by Wells Fargo in 2008, Wachovia was the fourth-largest bank holding company in the United States based on total assets. Wachovia provided a broad range of banking, asset management, wealth management, and corporate and investment banking products and services. At its height, it was one of the largest providers of financial services in the United States, operating financial centers in 21 states and Washington, D.C., with locations from Connecticut to Florida and west to California.

Wells Fargo & Co.

Wells Fargo is drawing attention ahead of its Q3 earnings as bank shares face pressure from rising Treasury yields and concerns about margins and deposit costs. Traders are split between buying the pullbackciting Wells Fargos Morgan Stanley upgrade and improving prospects after the asset-cap removaland waiting for earnings to clarify the outlook.

Midnight is a privacy-first blockchain that blends public verifiability with confidential data handling. You can use Midnight's selective disclosure and ZK proofs to build apps.

Midnight

NIGHT traders are weighing a rebound against lingering concerns from the Wanchain bridge exploit and ongoing airdrop/unlock-related selling. Bulls point to the mainnet rollout, validator and partnership developments, and reported Coinbase availability as signs of adoption, while skeptics remain cautious about supply pressure and the exploits impact on confidence.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

COMP is drawing attention for a technical rebound, with traders watching a break above resistance near $26$27 and citing bullish chart patterns. Many are optimistic about its capped token supply and planned V4 and institutional-market expansion, while others remain frustrated by uneven price action; the breakout thesis is speculative.

Cameco Corp. engages in the provision of uranium. It operates through the Uranium and Fuel Services segments. The Uranium segment is involved in the exploration for, mining, milling, purchase, and sale of uranium concentrate. The Fuel Services segment deals with the refining, conversion, and fabrication of uranium concentrate and the purchase and sale of conversion services. The company was founded in 1988 and is headquartered in Saskatoon, Canada.

Cameco Corp.

Cameco is drawing attention amid a sharp pullback across uranium and nuclear stocks, with traders divided over whether the shares are forming a bottom or facing further pressure as enthusiasm for the nuclear theme cools. Cigar Lakes temporary production suspension added supply concerns, though Cameco said operations resumed and its production outlook was unchanged; bulls continue to cite long-term nuclear demand and Westinghouse exposure.

Hyperliquid is a layer one (L1) blockchain best known for perpetual futures and spot trading. Beyond its flagship DEX trading platform, the ecosystem supports borrowing, lending, real world assets (RWAs), and a full-fledged Ethereum Virtual Machine (EVM), making it a leading force in decentralized finance (defi).   Just as electronic trading dramatically improved markets in the 2000s, Hyperliquid offers an opportunity for a massive technical upgrade of the existing financial system through a transparent, efficient, and resilient blockchain. HYPE is the native token of the Hyperliquid blockchain, with a maximum supply of 1 billion.

Hype

Hyperliquids buyback-and-burn program, funded by protocol revenue, is a major focus as traders react to HYPEs rally and fresh highs. Bulls see recurring buybacks and growing platform activity as supportive, while others point to token unlocks, profit-taking, and pullback risk.

Tidal Trust II - Defiance Daily Target 2x Long MSTR ETF

Defiance Daily Target 2x Long MSTR ETF

Bitcoins rebound and traders view that it may have bottomed are fueling bullish interest in MSTX, a 2x leveraged MSTR ETF. Some traders remain cautious about its volatility and leverage decay, with bearish options activity viewed by some as hedging rather than a directional bet.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Brief India: Aequitas: Shiprocket Limited Pre-IPO Tearsheet and more

In this briefing: Aequitas: Shiprocket Limited Pre-IPO Tearsheet Titan’s LGD Move: Expanding Diamond Adoption with BeYon Somany Ceramics: Recovery Building, Normalcy Distant. Maintain ADD Pharma and Healthcare (Q3FY26E Results Preview): Base business momentum to offset gRevlimid drag Aptus Value Housing Finance India: Value Emerging, Upgrade to ADD 1. Aequitas: Shiprocket Limited Pre-IPO Tearsheet Shiprocket Ltd (1087190D IN) plans to raise around US$253m in its upcoming India IPO. The deal will be run by Axis, BofA, JM Fin and Kotak. Shiprocket is a technology platform enabling small and medium businesses in India to sell online through their own websites, mobile apps, and social media channels efficiently. According to the Redseer report, Shiprocket was the largest new-age end-to-end horizontal e-commerce enablement platform in terms of revenue in FY25. 2. Titan’s LGD Move: Expanding Diamond Adoption with BeYon Titan delivered blockbuster jewellery performance despite a ~65% YoY surge in gold prices and launched beYon , its lab-grown diamond brand.

Brief Growth Ideas: Titan’s LGD Move: Expanding Diamond Adoption with BeYon and more

In this briefing: Titan’s LGD Move: Expanding Diamond Adoption with BeYon Primer: Piotech (688072 CH) - Jan 2026 Somany Ceramics: Recovery Building, Normalcy Distant. Maintain ADD Pharma and Healthcare (Q3FY26E Results Preview): Base business momentum to offset gRevlimid drag Aptus Value Housing Finance India: Value Emerging, Upgrade to ADD 1. Titan’s LGD Move: Expanding Diamond Adoption with BeYon Titan delivered blockbuster jewellery performance despite a ~65% YoY surge in gold prices and launched beYon , its lab-grown diamond brand. Strong pricing power funds experimentation; LGDs expand diamond adoption among younger buyers without cannibalizing natural diamonds. BeYon adds long-term relevance and optionality while the core jewellery engine remains cash generative. 2. Primer: Piotech (688072 CH) - Jan 2026 Piotech is a key beneficiary of China's strategic push for semiconductor self-sufficiency, driving substantial revenue growth and market share gains within the domestic market. The company exhibits a robust growth profile, evidenced by a significant increase in revenue and net income over the past three years, supported by strong demand for its core deposition equipment.

Brief India: Titan’s LGD Move: Expanding Diamond Adoption with BeYon and more

In this briefing: Titan’s LGD Move: Expanding Diamond Adoption with BeYon Somany Ceramics: Recovery Building, Normalcy Distant. Maintain ADD Pharma and Healthcare (Q3FY26E Results Preview): Base business momentum to offset gRevlimid drag Aptus Value Housing Finance India: Value Emerging, Upgrade to ADD Q3FY26 - Consolidated Earnings Preview 1. Titan’s LGD Move: Expanding Diamond Adoption with BeYon Titan delivered blockbuster jewellery performance despite a ~65% YoY surge in gold prices and launched beYon , its lab-grown diamond brand. Strong pricing power funds experimentation; LGDs expand diamond adoption among younger buyers without cannibalizing natural diamonds. BeYon adds long-term relevance and optionality while the core jewellery engine remains cash generative. 2. Somany Ceramics: Recovery Building, Normalcy Distant. Maintain ADD We attended Somany Ceramics' analyst meet, represented by Mr Abhishek Somany (MD and CEO), Mr Sailesh Kedawat (CFO), and Mr Ameya Somany (KMP – son of MD) Management indicated that demand is showing signs of recovery Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only.

Brief Growth Ideas: Primer: Piotech (688072 CH) - Jan 2026 and more

In this briefing: Primer: Piotech (688072 CH) - Jan 2026 Somany Ceramics: Recovery Building, Normalcy Distant. Maintain ADD Pharma and Healthcare (Q3FY26E Results Preview): Base business momentum to offset gRevlimid drag Aptus Value Housing Finance India: Value Emerging, Upgrade to ADD The Cuban Gold Rush? 1. Primer: Piotech (688072 CH) - Jan 2026 Piotech is a key beneficiary of China's strategic push for semiconductor self-sufficiency, driving substantial revenue growth and market share gains within the domestic market. The company exhibits a robust growth profile, evidenced by a significant increase in revenue and net income over the past three years, supported by strong demand for its core deposition equipment. Valuation appears stretched, with key multiples trading at a significant premium to global peers, reflecting high growth expectations but also posing a risk of de-rating if execution falters or market conditions change. This content is AI-generated and displayed for general informational purposes only.

Brief Growth Ideas: Somany Ceramics: Recovery Building, Normalcy Distant. Maintain ADD and more

In this briefing: Somany Ceramics: Recovery Building, Normalcy Distant. Maintain ADD Pharma and Healthcare (Q3FY26E Results Preview): Base business momentum to offset gRevlimid drag Aptus Value Housing Finance India: Value Emerging, Upgrade to ADD The Cuban Gold Rush? The Gfc Distressed Preferred Stock Opportunity (Fnmat & More) 1. Somany Ceramics: Recovery Building, Normalcy Distant. Maintain ADD We attended Somany Ceramics' analyst meet, represented by Mr Abhishek Somany (MD and CEO), Mr Sailesh Kedawat (CFO), and Mr Ameya Somany (KMP – son of MD) Management indicated that demand is showing signs of recovery Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below. 2. Pharma and Healthcare (Q3FY26E Results Preview): Base business momentum to offset gRevlimid drag The India Pharma and Healthcare sector is expected to see moderate revenue growth as EBITDA margins remain flat We project sales/EBITDA growth of 11%/10% YoY for our coverage universe Our assumptions are: (1) Pharma coverage will see 10% YoY sales growth driven by 11% YoY increase in the India business Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only.

Brief India: Somany Ceramics: Recovery Building, Normalcy Distant. Maintain ADD and more

In this briefing: Somany Ceramics: Recovery Building, Normalcy Distant. Maintain ADD Pharma and Healthcare (Q3FY26E Results Preview): Base business momentum to offset gRevlimid drag Aptus Value Housing Finance India: Value Emerging, Upgrade to ADD Q3FY26 - Consolidated Earnings Preview Minda Corporation Ltd- Forensic Analysis 1. Somany Ceramics: Recovery Building, Normalcy Distant. Maintain ADD We attended Somany Ceramics' analyst meet, represented by Mr Abhishek Somany (MD and CEO), Mr Sailesh Kedawat (CFO), and Mr Ameya Somany (KMP – son of MD) Management indicated that demand is showing signs of recovery Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below. 2. Pharma and Healthcare (Q3FY26E Results Preview): Base business momentum to offset gRevlimid drag The India Pharma and Healthcare sector is expected to see moderate revenue growth as EBITDA margins remain flat We project sales/EBITDA growth of 11%/10% YoY for our coverage universe Our assumptions are: (1) Pharma coverage will see 10% YoY sales growth driven by 11% YoY increase in the India business Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only.

Brief Growth Ideas: Pharma and Healthcare (Q3FY26E Results Preview): Base business momentum to offset gRevlimid drag and more

In this briefing: Pharma and Healthcare (Q3FY26E Results Preview): Base business momentum to offset gRevlimid drag Aptus Value Housing Finance India: Value Emerging, Upgrade to ADD The Cuban Gold Rush? The Gfc Distressed Preferred Stock Opportunity (Fnmat & More) Q3FY26 - Consolidated Earnings Preview 1. Pharma and Healthcare (Q3FY26E Results Preview): Base business momentum to offset gRevlimid drag The India Pharma and Healthcare sector is expected to see moderate revenue growth as EBITDA margins remain flat We project sales/EBITDA growth of 11%/10% YoY for our coverage universe Our assumptions are: (1) Pharma coverage will see 10% YoY sales growth driven by 11% YoY increase in the India business Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below. 2. Aptus Value Housing Finance India: Value Emerging, Upgrade to ADD APTUS remains focused on the core customer segment - LIG, self-employed and rural-based customers, constituting >70% of AUM to scale up its portfolio to INR 250bn by FY29 The company’s superior profitability (~7.5% RoA, ~19-20% RoE) stems from strong risk-adjusted yields (~17%), superior operating efficiency (CI at 20%, opex to assets at 2.7%) and low leverage (D/E at 1.6x) However, APTUS’s scalability outside core markets and core products has been protracted over the last few years Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only.

Brief Equities Bottom-Up: Aptus Value Housing Finance India: Value Emerging, Upgrade to ADD and more

In this briefing: Aptus Value Housing Finance India: Value Emerging, Upgrade to ADD Samsung Electronics (005930 KS Jan 8, 2025) - No Signs of Slowing Vale Indonesia (INCO.IJ) On-Track Ore Monetization to Drive FY26-27 Earnings S-Oil (010950 KS/Buy)Refining Margins to Remain Strong into 2026 LODE: Final Permitting Paves Way for Silver Springs Facility Commissioning 1. Aptus Value Housing Finance India: Value Emerging, Upgrade to ADD APTUS remains focused on the core customer segment - LIG, self-employed and rural-based customers, constituting >70% of AUM to scale up its portfolio to INR 250bn by FY29 The company’s superior profitability (~7.5% RoA, ~19-20% RoE) stems from strong risk-adjusted yields (~17%), superior operating efficiency (CI at 20%, opex to assets at 2.7%) and low leverage (D/E at 1.6x) However, APTUS’s scalability outside core markets and core products has been protracted over the last few years Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only.

Indian Markets Reverse Early Gains: Yes Bank, Adani, Vodafone Shares Under Pressure

Equity

Nifty consolidates below key resistance level. An analyst flags 24,800 as the breakout level, while broader indices outperform. 


Aptus Value Housing Finance India Ltd. engages in the provision of housing finance needs of low income and middle income customers. Its products include home loans, non-housing loan, insurance services, and loan against property. The company was founded by Munusamy Anandan on December 11, 2009 and is headquartered in Chennai, India.

Current Price	215.00
Prev Close	217.89
Open	215.52
Dividend Yield	2.31%
50-Day Moving Average	247.85
Beta	-0.06
Avg. Volume	1.72M
PE Ratio	10.97

52-Week High	322.75
52-Week Low	193.03
Market Capitalization	108.15B
EPS (Annual)	18.84
Price to Book	2.13
Revenue Per Employee	5.89M

Feed

News

Sentiment

Fundamentals

Info

APTUS.NSE Fundamentals